CERAZETTE

This brand name is authorized in Austria, Brazil, Ecuador, Estonia, Finland, France, Ireland, Israel, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom, South Africa

Active ingredients

The drug CERAZETTE contains one active pharmaceutical ingredient (API):

1 Desogestrel UNII 81K9V7M3A3 - DESOGESTREL

Desogestrel is a progestogen. Like other progestogen-only pills, desogestrel is best suited for use during breast feeding and for women who may not or do not want to use oestrogens. In contrast to traditional progestogen-only pills, the contraceptive effect of desogestrel is achieved primarily by inhibition of ovulation. Other effects include increased viscosity of the cervical mucus. Read about Desogestrel

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CERAZETTE Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G03AC09	Desogestrel	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AC Progestogens
Discover more medicines within G03AC09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 527300201110312, 527313010009603
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 26.224-03-05
Country: EE	Ravimiamet	Identifier(s): 1010675, 1063303, 1063314, 1589519, 1861871, 1861882, 1861893
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 518332
Country: FR	Base de données publique des médicaments	Identifier(s): 61452187
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 34116
Country: IE	Health Products Regulatory Authority	Identifier(s): 65410
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4758, 4759
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1014148, 1014149, 1067338, 1067339, 1087556
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 331M99
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 56111
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8026
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100106907, 100265920, 100269012, 100300207, 100304501, 100309125, 100335016, 100335281, 100342447, 100342683, 100361870, 100396839, 100420176, 100432280, 100432788, 100447034, 100456995
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68119001, W68119002, W68119003
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8683280337046
Country: ZA	Health Products Regulatory Authority	Identifier(s): 46/34/0891